Fenofibrate, a peroxisome proliferator-activated receptor α agonist, exerts neuroprotective effects in traumatic brain injury

This publication has 29 references indexed in Scilit:

• Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord trauma
  Experimental Neurology, 2005
• WY 14643, A POTENT EXOGENOUS PPAR-?? LIGAND, REDUCES INTESTINAL INJURY ASSOCIATED WITH SPLANCHNIC ARTERY OCCLUSION SHOCK
  Shock, 2004
• Fenofibrate Impairs Rat Mitochondrial Function by Inhibition of Respiratory Complex I
  The Journal of Pharmacology and Experimental Therapeutics, 2004
• Global Suppression of IL-6-induced Acute Phase Response Gene Expression after Chronic in Vivo Treatment with the Peroxisome Proliferator-activated Receptor-α Activator Fenofibrate
  Journal of Biological Chemistry, 2004
• Isotretinoin and fenofibrate induce adiposity with distinct effect on metabolic profile in a rat model of the insulin resistance syndrome
  International Journal of Obesity, 2004
• Peroxisome Proliferator–activated Receptors α and γ Down-regulate Allergic Inflammation and Eosinophil Activation
  Journal of Experimental Medicine, 2003
• Cyclooxygenase-2, Prostaglandin Synthases, and Prostaglandin H ₂ Metabolism in Traumatic Brain Injury in the Rat
  Journal of Neurotrauma, 2002
• Peroxisome Proliferator-activated Receptor α Activation Modulates Cellular Redox Status, Represses Nuclear Factor-κB Signaling, and Reduces Inflammatory Cytokine Production in Aging
  Journal of Biological Chemistry, 1998
• Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue
  Molecular Psychiatry, 1997
• The PPARα–leukotriene B4 pathway to inflammation control
  Nature, 1996